A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community

Haemophilia

Volumn 9, Issue 3, 2003, Pages 245-250

  Stonebraker, Jeffrey S ^a   Amand, R E ^a   Nagle, A J ^b  

^a BAYER CORPORATION   (United States)

^b NONE   (United States)

Author keywords

Developing world; Factor VIII concentrates; Health economics

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE;

ANALYTIC METHOD; ARTICLE; CALCULATION; CAREGIVER; COMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MARKETING; DRUG USE; ECONOMIC EVALUATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HEMOPHILIA A; HUMAN; INCOME; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

EID: 0037764749     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00758.x     Document Type: Article

References (23)

1. Evatt BL. Observations from Global Survey 2001: an emerging database for progress. Haemophilia 2002; 8: 153-6.
2. Evatt BL, Robillard L. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism. Haemophilia 2000; 6: 131-4.
3. Berman PA. National health accounts in developing countries: appropriate methods and recent applications. Health Econ 1997; 6: 11-30.
4. Jones P. Haemophilia: a global challenge. Haemophilia 1995; 1: 11-3.
5. Antunes SV. Haemophilia in the developing world: the Brazilian experience. Haemophilia 2002; 8: 199-204.
6. Chandy M. Management of haemophilia in developing countries with available resources. Haemophilia 1995; 1 (Suppl. 1): 44-8.
7. Srivastava A. Delivery of haemophilia care in the developing world. Haemophilia 1998; 4 (Suppl. 2): 33-40.
8. Srivastava A, Chuansumrit A, Chandy M, Duraiswamy G, Karagus C. Management of haemophilia in the developing world. Haemophilia 1998; 4: 474-80.
9. Bird A, Isarangkura P, Almagro D, Gonzaga A, Srivastava A. Factor concentrates for haemophilia in the developing world. Haemophilia 1998; 4: 481-5.
10. Evatt BL. Public health and international health-care development for persons with haemophilia: operation improvement and operation access. Haemophilia 1998; 4 (Suppl. 2): 54-8.
11. Lee CA. Towards achieving global haemophilia care - World Federation of Hemophilia programmes. Haemophilia 1998; 4: 463-73.
12. World Federation of Hemophilia. Report on the WFH Global Survey 2001. Montreal, Canada: WFH, 2001.
13. Market Research Bureau, Inc. The Plasma Fractions Market in Asia and Pacific - 2000 Vol. A, B and C, Orange, CT: MRB, 2001.
14. Market Research Bureau, Inc. The Plasma Fractions Market in the United States - 2000 Orange, CT: MRB, 2001.
15. Market Research Bureau, Inc. The Plasma Fractions Market in the Middle East - 2000 Orange, CT: MRB, 2001.
16. Market Research Bureau, Inc. The Plasma Fractions Market in Europe - 1999 Vol. A, B and C, Orange, CT: MRB, 2000.
17. Market Research Bureau, Inc. The Plasma Fractions Market in Central and South America - 1998 Vol. A and B, Orange, CT: MRB, 1999.
18. Isarangkura P. Haemophilia care in the developing world: benchmarking for excellence. Haemophilia 2002; 8: 205-10.
19. World Bank Group. World Development Indicators 3rd edn. Washington, DC: World Bank, 2001.
20. Almanac. New York Times 2000 Almanac New York, NY: Penguin Group, 1999.
21. Economist. Pocket World in Figures, 2001 Edition London, UK: Profile Books Ltd, 2001.
22. World Health Organization. The World Health Report 2001: Mental Health, New Understanding, New Hope Geneva, Switzerland: WHO, 2001.
23. United Nations. The Sex and Age Distribution of the World Populations. The 1996 Revision New York, NY: UN, 1997.